208 related articles for article (PubMed ID: 9369533)
1. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans.
Ashcroft GS; Horan MA; Herrick SE; Tarnuzzer RW; Schultz GS; Ferguson MW
Cell Tissue Res; 1997 Dec; 290(3):581-91. PubMed ID: 9369533
[TBL] [Abstract][Full Text] [Related]
2. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds.
Mirastschijski U; Impola U; Jahkola T; Karlsmark T; AGren MS; Saarialho-Kere U
Hum Pathol; 2002 Mar; 33(3):355-64. PubMed ID: 11979378
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase activity during wound healing.
Agren MS
Br J Dermatol; 1994 Nov; 131(5):634-40. PubMed ID: 7999593
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds.
Nwomeh BC; Liang HX; Diegelmann RF; Cohen IK; Yager DR
Wound Repair Regen; 1998; 6(2):127-34. PubMed ID: 9776855
[TBL] [Abstract][Full Text] [Related]
6. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity.
Pilcher BK; Wang M; Qin XJ; Parks WC; Senior RM; Welgus HG
Ann N Y Acad Sci; 1999 Jun; 878():12-24. PubMed ID: 10415717
[TBL] [Abstract][Full Text] [Related]
7. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase by myofibroblasts--morphological study on corneal wound healing].
Shimoda M; Ishizaki M; Saiga T; Yamanaka N
Nippon Ganka Gakkai Zasshi; 1997 May; 101(5):371-9. PubMed ID: 9170840
[TBL] [Abstract][Full Text] [Related]
8. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds.
Madlener M
Arch Dermatol Res; 1998 Jul; 290 Suppl():S24-9. PubMed ID: 9710380
[TBL] [Abstract][Full Text] [Related]
10. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
11. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
12. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2 and -9 during early human wound healing.
Salo T; Mäkelä M; Kylmäniemi M; Autio-Harmainen H; Larjava H
Lab Invest; 1994 Feb; 70(2):176-82. PubMed ID: 8139259
[TBL] [Abstract][Full Text] [Related]
14. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9.
Tarlton JF; Vickery CJ; Leaper DJ; Bailey AJ
Br J Dermatol; 1997 Oct; 137(4):506-16. PubMed ID: 9390324
[TBL] [Abstract][Full Text] [Related]
15. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
16. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA.
Ashcroft GS; Herrick SE; Tarnuzzer RW; Horan MA; Schultz GS; Ferguson MW
J Pathol; 1997 Oct; 183(2):169-76. PubMed ID: 9390029
[TBL] [Abstract][Full Text] [Related]
17. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
19. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
20. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
